Concepedia

Katherine Delaria

KD

Statistics

Publications

6

Citations

401

H-Index

6

Active since

1991

Affiliations

Bayer (United States)(Current)

University of California, Berkeley

Katherine Delaria is an author at Bayer (United States) specializing in life sciences, molecular biology, and biochemistry.

Publications per year

1991–2024

6

Publications

6

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo

Armen B. Shanafelt, Yue Lin, Marie-Claude Shanafelt et al. · Nature Biotechnology · 2000 · 133 citations

, , +14

Characterization of Placental Bikunin, a Novel Human Serine Protease Inhibitor

Katherine Delaria, Daniel K. Muller, Christopher W. Marlor et al. · Journal of Biological Chemistry · 1997 · 100 citations · Full text

, , +12

Identification and Cloning of Human Placental Bikunin, a Novel Serine Protease Inhibitor Containing Two Kunitz Domains

Christopher W. Marlor, Katherine Delaria, Gary L. Davis et al. · Journal of Biological Chemistry · 1997 · 83 citations · Full text

, , +9

Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta.

Katherine Delaria, L. Fiorentino, Lane J. Wallace et al. · Journal of Biological Chemistry · 1994 · 54 citations · Full text

, , +10

Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies

Melissa A. Calton, Roxanne H. Croze, Christian Burns et al. · Investigative Ophthalmology & Visual Science · 2024 · 18 citations · Full text

, , +17

1–5 of 6